November 25, 2024

GSK eyes up combo approval for previously withdrawn myeloma drug – Pharmaceutical Technology

November 25, 2024

HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals Announce Successful Completion of a First-in-Human Study for Potential Disease-Modifying Therapy for Parkinson’s Disease – PR Newswire

November 25, 2024

Cassava’s Shares Plunge as Alzheimer’s Drug Fails Phase 3 – BioSpace

November 25, 2024

Cassava shares plunge 85% as Alzheimer’s study fails to meet endpoints – Investing.com

November 25, 2024

GSK’s Blenrep Nears FDA Review for Myeloma – TipRanks